Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-07 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |